BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34893887)

  • 1. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
    Bernaudat F; Gustems M; Günther J; Oliva MF; Buschle A; Göbel C; Pagniez P; Lupo J; Signor L; Müller CW; Morand P; Sattler M; Hammerschmidt W; Petosa C
    Nucleic Acids Res; 2022 Jan; 50(1):490-511. PubMed ID: 34893887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-methylation regulates a class of Epstein-Barr virus promoters.
    Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
    PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein.
    Karlsson QH; Schelcher C; Verrall E; Petosa C; Sinclair AJ
    PLoS Pathog; 2008 Mar; 4(3):e1000005. PubMed ID: 18369464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Noncanonical Basic Motif of Epstein-Barr Virus ZEBRA Protein Facilitates Recognition of Methylated DNA, High-Affinity DNA Binding, and Lytic Activation.
    Weber E; Buzovetsky O; Heston L; Yu KP; Knecht KM; El-Guindy A; Miller G; Xiong Y
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.
    Ramasubramanyan S; Kanhere A; Osborn K; Flower K; Jenner RG; Sinclair AJ
    J Virol; 2012 Dec; 86(23):12494-502. PubMed ID: 23015699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
    Kalla M; Göbel C; Hammerschmidt W
    J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
    Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
    J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.
    Flower K; Thomas D; Heather J; Ramasubramanyan S; Jones S; Sinclair AJ
    PLoS One; 2011; 6(10):e25922. PubMed ID: 22022468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL; Taylor N; Gradoville L; Countryman J; Miller G
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
    Woellmer A; Arteaga-Salas JM; Hammerschmidt W
    PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
    J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.
    Yu KP; Heston L; Park R; Ding Z; Wang'ondu R; Delecluse HJ; Miller G
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8176-81. PubMed ID: 23625009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
    Francis AL; Gradoville L; Miller G
    J Virol; 1997 Apr; 71(4):3054-61. PubMed ID: 9060666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.
    Zhao M; Nanbo A; Becnel D; Qin Z; Morris GF; Li L; Lin Z
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.
    Dickerson SJ; Xing Y; Robinson AR; Seaman WT; Gruffat H; Kenney SC
    PLoS Pathog; 2009 Mar; 5(3):e1000356. PubMed ID: 19325883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a prediction protocol to identify potential targets of epigenetic reprogramming by the cancer associated Epstein Barr virus.
    Flower K; Hellen E; Newport MJ; Jones S; Sinclair AJ
    PLoS One; 2010 Feb; 5(2):e9443. PubMed ID: 20195470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
    Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
    Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
    Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.